Remgro (REM) H1 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 TU earnings summary
13 Mar, 2026Executive summary
Headline earnings per share (HEPS) for the six months ended 31 December 2025 expected to rise significantly year-over-year.
Results will be officially released on or about 25 March 2026.
Financial highlights
HEPS anticipated between 914 cents and 948 cents, up from 672 cents in the prior year period.
This represents an increase of 36% to 41% compared to the same period last year.
Outlook and guidance
The increase in HEPS is attributed to improved operational performance across most investee companies.
Further details on earnings drivers will be provided with the full results release.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Remgro
- Headline earnings down 20%, dividend up 10%, with strong OUTsurance and RCL Foods results.REM
H2 202420 Jan 2026 - All resolutions passed as shareholders engaged on strategy, incentives, and global risks.REM
AGM 202412 Jan 2026 - Portfolio is 63% private, with growth led by Mediclinic and CIVH, and focus on ESG and performance.REM
CMD 202520 Dec 2025 - Headline earnings up 38.7%, INAV per share up 10.3%, and dividend up 20%.REM
H1 20251 Dec 2025 - Maziv's ZAR 38.75bn deal advances with regulatory support, CapEx, and BEE commitments.REM
Investor Update13 Nov 2025 - Headline earnings up 38.6%, ordinary dividend up 30.3%, and balance sheet fully de-geared.REM
H2 202516 Oct 2025